Search results
Author(s):
Sivabaskari Pasupathy
,
Rosanna Tavella
,
Simon McRae
,
et al
Added:
3 years ago
Early coronary angiography performed during acute MI (AMI) identifies an occluded vessel in most patients with ST elevation MI (STEMI)1 and less frequently in those with non-STEMI;2 however, ≥90 % of patients with AMI have evidence of obstructive coronary artery disease.3 For these patients with overt coronary artery disease (CAD), the benefits of reperfusion strategies and cardioprotective…
View more
Author(s):
Gaetano Antonio Lanza
Added:
3 years ago
Up to 50% of patients who undergo elective coronary angiography for stable chest pain symptoms that are mainly related to exercise and typical enough to suggest the presence of obstructive coronary artery disease (CAD) are found to have normal or near-normal coronary arteries.1 The mechanisms responsible for angina chest pain in these patients are heterogeneous; accordingly, their identification…
View more
Author(s):
Mario Petretta
,
Pierluigi Costanzo
,
Alberto Cuocolo
Added:
3 years ago
Myocardial blood flow (MBF) must respond to changes in metabolic conditions and oxygen requests to meet the needs of myocytes, and autoregulation plays a mayor role in the control of coronary circulation.1–3 It has been demonstrated that, as a coronary artery is progressively narrowed, resting flow does not change at first, but maximal flow (achieved by injecting a vasodilator) decreases…
View more
Author(s):
Maria Grazia Modena
,
Annachiara Nuzzo
,
Rosario Rossi
,
et al
Added:
3 years ago
Women with angina but no obstructive coronary artery disease (CAD) at coronary angiography have long been considered a low-risk population.1–3 Instead, data from the Women‘s ischaemia syndrome evaluation (WISE) study4 demonstrated that persistent chest pain (PChP) – also in the absence of CAD – is not a benign condition. These patients experienced major cardiovascular (CV) events, such as…
View more
Author(s):
Olivia Manfrini
,
Peter Amaduzzi
,
Maria Bergami
,
et al
Added:
3 years ago
Statins are commonly used in patients with hypercholesterolaemia and in those with cardiovascular diseases – that is, peripheral artery disease and coronary artery disease (CAD) – for the prevention of atheromatous plaque development, progression and complications, with the aim of reducing subsequent major adverse cardiovascular events (MACE), i.e. cardiac death, acute MI, stroke and heart…
View more
Stable Angina Medical Therapy
Author(s):
Talla A Rousan
,
Udho Thadani
Added:
3 years ago
Article
Author(s):
Tracey Keteepe-Arachi
,
Sanjay Sharma
Added:
3 years ago
Globally, cardiovascular disease (CVD) remains the leading cause of mortality in women. Approximately 2.8 million women have been diagnosed with CVD in the UK.1 For many years, the presence of gender-related differences in presentation, risk factors and outcomes have been recognised. Importantly, these discrepancies in presentation and outcomes between the sexes are often associated with…
View more
Author(s):
Thomas Wolber
Added:
3 years ago
Coronary artery disease (CAD) is the leading cause of death in adults, accounting for more than 480,000 deaths in the US and 1.95 million deaths in Europe each year. There is considerable interest in early diagnosis of CAD, because obstructive coronary artery disease can exist with minimal or no symptoms and can progress rapidly. In patients with symptoms suggestive of CAD, a variety of tests and…
View more
Author(s):
Andrea Aparicio
,
Javier Cuevas
,
César Morís
,
et al
Added:
2 years ago
Author(s):
Marie Mide Michelsen
,
Naja Dam Mygind
,
Daria Frestad
,
et al
Added:
3 years ago
Women have for many years been regarded as being at relatively low risk for the development of ischaemic heart disease (IHD).1,2 Recently this pattern has changed and cardiovascular disease (CVD) is now the leading cause of death for women in Europe.3,4 Under the age of 60 years acute coronary syndrome occurs 3–4 times more often in men; however, after the age of 75 years women represent the…
View more